PortalPublikationen[New aspects in the therapy of recurrence and metastasis of ...

[New aspects in the therapy of recurrence and metastasis of head and neck cancer: highlights from the 2012 ASCO meeting].

Standard

[New aspects in the therapy of recurrence and metastasis of head and neck cancer: highlights from the 2012 ASCO meeting]. / Schöpper, Steffen; Laban, Simon; Güldenzoph, Björn; Münscher, Adrian; Knecht, Rainald; Kurzweg, Thiemo.

in: HNO, Jahrgang 60, Nr. 11, 11, 2012, S. 957-961.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Schöpper, S, Laban, S, Güldenzoph, B, Münscher, A, Knecht, R & Kurzweg, T 2012, '[New aspects in the therapy of recurrence and metastasis of head and neck cancer: highlights from the 2012 ASCO meeting].', HNO, Jg. 60, Nr. 11, 11, S. 957-961. <http://www.ncbi.nlm.nih.gov/pubmed/23114541?dopt=Citation>

APA

Schöpper, S., Laban, S., Güldenzoph, B., Münscher, A., Knecht, R., & Kurzweg, T. (2012). [New aspects in the therapy of recurrence and metastasis of head and neck cancer: highlights from the 2012 ASCO meeting]. HNO, 60(11), 957-961. [11]. http://www.ncbi.nlm.nih.gov/pubmed/23114541?dopt=Citation

Vancouver

Schöpper S, Laban S, Güldenzoph B, Münscher A, Knecht R, Kurzweg T. [New aspects in the therapy of recurrence and metastasis of head and neck cancer: highlights from the 2012 ASCO meeting]. HNO. 2012;60(11):957-961. 11.

Bibtex

@article{b03b621d0c544bc4adb67892327f3761,
title = "[New aspects in the therapy of recurrence and metastasis of head and neck cancer: highlights from the 2012 ASCO meeting].",
abstract = "The majority of patients with a squamous cell carcinoma of the head and neck region (HNSCC) initially present in a locally advanced stage of the disease. Despite aggressive protocols in first-line treatment, some of these patients develop locoregional recurrences or metastases and are, in particular, extraordinarily challenging for the multidisciplinary treatment team. Therefore, among resectability and prior therapy, age, performance status and individual expectations of the patient have to be taken into account. Apart from surgical options like salvage surgery, chemotherapy and target therapy as well as reirradiation are possible treatment concepts. Unfortunately, most treatment options offer only little to no survival benefit.",
keywords = "Humans, Lymphatic Metastasis, Carcinoma/*secondary/*therapy, Medical Oncology/*trends, Head and Neck Neoplasms/*therapy, Neoplasm Recurrence, Local/*therapy, Humans, Lymphatic Metastasis, Carcinoma/*secondary/*therapy, Medical Oncology/*trends, Head and Neck Neoplasms/*therapy, Neoplasm Recurrence, Local/*therapy",
author = "Steffen Sch{\"o}pper and Simon Laban and Bj{\"o}rn G{\"u}ldenzoph and Adrian M{\"u}nscher and Rainald Knecht and Thiemo Kurzweg",
year = "2012",
language = "Deutsch",
volume = "60",
pages = "957--961",
journal = "HNO",
issn = "0017-6192",
publisher = "Springer",
number = "11",

}

RIS

TY - JOUR

T1 - [New aspects in the therapy of recurrence and metastasis of head and neck cancer: highlights from the 2012 ASCO meeting].

AU - Schöpper, Steffen

AU - Laban, Simon

AU - Güldenzoph, Björn

AU - Münscher, Adrian

AU - Knecht, Rainald

AU - Kurzweg, Thiemo

PY - 2012

Y1 - 2012

N2 - The majority of patients with a squamous cell carcinoma of the head and neck region (HNSCC) initially present in a locally advanced stage of the disease. Despite aggressive protocols in first-line treatment, some of these patients develop locoregional recurrences or metastases and are, in particular, extraordinarily challenging for the multidisciplinary treatment team. Therefore, among resectability and prior therapy, age, performance status and individual expectations of the patient have to be taken into account. Apart from surgical options like salvage surgery, chemotherapy and target therapy as well as reirradiation are possible treatment concepts. Unfortunately, most treatment options offer only little to no survival benefit.

AB - The majority of patients with a squamous cell carcinoma of the head and neck region (HNSCC) initially present in a locally advanced stage of the disease. Despite aggressive protocols in first-line treatment, some of these patients develop locoregional recurrences or metastases and are, in particular, extraordinarily challenging for the multidisciplinary treatment team. Therefore, among resectability and prior therapy, age, performance status and individual expectations of the patient have to be taken into account. Apart from surgical options like salvage surgery, chemotherapy and target therapy as well as reirradiation are possible treatment concepts. Unfortunately, most treatment options offer only little to no survival benefit.

KW - Humans

KW - Lymphatic Metastasis

KW - Carcinoma/secondary/therapy

KW - Medical Oncology/trends

KW - Head and Neck Neoplasms/therapy

KW - Neoplasm Recurrence, Local/therapy

KW - Humans

KW - Lymphatic Metastasis

KW - Carcinoma/secondary/therapy

KW - Medical Oncology/trends

KW - Head and Neck Neoplasms/therapy

KW - Neoplasm Recurrence, Local/therapy

M3 - SCORING: Zeitschriftenaufsatz

VL - 60

SP - 957

EP - 961

JO - HNO

JF - HNO

SN - 0017-6192

IS - 11

M1 - 11

ER -